Point72 Hong Kong’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-544
Closed -$53K 1684
2020
Q2
$53K Buy
544
+78
+17% +$6.51K 0.01% 729
2020
Q1
$22K Buy
466
+192
+70% +$12.3K 0.01% 534
2019
Q4
$20K Buy
+274
New +$16.6K ﹤0.01% 889
2018
Q4
Sell
-221
Closed -$14K 1334
2018
Q3
$14K Buy
+221
New +$13K ﹤0.01% 633
2017
Q4
Sell
-20
Closed -$1K 1192
2017
Q3
$1K Buy
+20
New +$638 ﹤0.01% 749
2017
Q2
Sell
-158
Closed -$2K 1112
2017
Q1
$2K Buy
+158
New +$2.02K ﹤0.01% 652

Other funds holding MYOK

Point72 Hong Kong's MYOK Position: Q3 2020 in Review

Point72 Hong Kong sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 544 shares — an estimated $53K sold.

Point72 Hong Kong first reported a position in MYOK in Q1 2017 and held it in 6 quarters. The position peaked at $53K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Point72 Hong Kong reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 544 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $53K.
  • Point72 Hong Kong first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
  • Point72 Hong Kong's MyoKardia, Inc. Common Stock position peaked at $53K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Point72 Hong Kong's 13F filing for Q3 2020, filed 16 Nov 2020.